Monitoring iron therapy in chronic heart failure

Abstract

This editorial refers to ‘The effect of intravenous ferriccarboxymaltoseonredcelldistributionwidth:asubanalysisof the FAIR-HF study,’ by E.M. Van Craenenbroeck et al.,published in this issue on pages 756–762.Iron deficiency has recently been identified as an important patho-genic factor affecting the severity and progression of chronic heartfailure(CHF).